Scientific Sessions 2024  /  Too Far Gone? Revascularization of Multivessel CAD in Severe Cardiomyopathy  /  Debate: PCI is the Optimal Modality for Management of Multivessel CAD and Severe Cardiomyopathy
Logo

American Heart Association

  180
  0

Final ID:

Debate: PCI is the Optimal Modality for Management of Multivessel CAD and Severe Cardiomyopathy

  • Mcentegart, Margaret  ( ColumbiaUniversityMedicalCenter , New York , New York , United States )
  • Perera, Divaka  ( St. Thomas' Hospital , London , United Kingdom )
    • Author Disclosures:
    Margaret McEntegart: DO have relevant financial relationships ; Consultant:Boston Scientific :Active (exists now) ; Consultant:Biosensors:Past (completed) ; Speaker:Medtronic:Past (completed) ; Speaker:Asahi:Past (completed) ; Consultant:Shockwave Medical:Active (exists now) | Divaka Perera: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Too Far Gone? Revascularization of Multivessel CAD in Severe Cardiomyopathy

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Complex Case #2 (multivessel CAD in low EF managed with PCI)

Mantha Aditya, Dugan Eunice, Del Cid Fratti Juan, Tiwana Jasleen

Debate: Surgery is the Optimal Modality for Management of Multivessel CAD in Patients with Severe Cardiomyopathy

Lawton Jennifer, Ruel Marc, Zwischenberger Brittany

You have to be authorized to contact abstract author. Please, Login
Not Available